Celebrate National Hispanic Heritage Month by expressing gratitude for Hispanic and Latinx visionaries, researchers, community members, and others who have expanded awareness about psychedelics. Taking …
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MAPS PBC) are committed to providing quality and comprehensive training and supervision …
Policy & Advocacy Updates This quarter marked an exciting period of growth and progress for MAPS’ Policy & Advocacy team. Through strategic partnerships, innovative research, coalition building, …
Washington, D.C., July 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) released an Ibogaine Investigator’s Brochure (IB), a comprehensive scientific and regulatory resource …
June, 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the opening of speaker submission for Psychedelic Science 2027 (PS27), its flagship conference for psychedelic …
June 18, 2026 — In United States v. Hemani, the U.S. Supreme Court ruled today that the federal government’s prosecution of Ali Hemani under a provision of the Gun Control Act violated the Second …
Washington, D.C., June 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced its Psychedelics for System-Impacted People (PSIP) project, a research, education, and …
Denver, Colorado; May 13, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) announced that early bird registrations are now open for Psychedelic Science 2027 (PS27), taking place …
SAN JOSE, CA; May 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced the addition of Liana Sananda Gillooly and Andrew “Mo” Septimus to its Board of Directors. …
DENVER, May 5, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a partnership with the Colorado Department of Revenue’s Natural Medicine Division to provide MAPS’ …
Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to …
As psychedelics enter the mainstream, new questions arise about how care models can serve diverse populations. To date, research has largely focused on veterans, first responders, and survivors of sexualized …